fda glp-1 compounding crackdown september 2025 🚨 Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of medications like semaglutide and tirzepatide, signaling a major shift in how these FDA cracks down on 'misleading'

Therapeutic peptides used in research settings are typically administered by injection or nasal spray under clinical oversight, while many over-the-counter products marketed as peptide supplements are unregulated and lack quality controls, according to the FDA

We are not taking any B vitamins orally

This distinction is especially important for clients with MTHFR genetic variants who have difficulty converting synthetic forms of B12

(December 2023)

(a) Three-chamber test assessment of sociability index, with results shown for MIA mice pre- and post-vehicle control or pre- and post- MT-II treatment (vehicle, n = 7

The most widely accepted classification for cutaneous LE is given by Gilliam et al., which classifies cutaneous LE into two major subtypes: LE-specific lesions and LE non-specific lesions based on the presence of interface dermatitis on histopathology